Original Research
Published on 18 Apr 2023
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution
in Cytokines and Soluble Mediators in Immunity
- 5,277 views
- 4 citations
Original Research
Published on 18 Apr 2023
in Cytokines and Soluble Mediators in Immunity
Original Research
Published on 18 Apr 2023
in Primary Immunodeficiencies
Original Research
Published on 18 Apr 2023
in Inflammation
Original Research
Published on 18 Apr 2023
in Nutritional Immunology
Original Research
Published on 18 Apr 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 18 Apr 2023
in Multiple Sclerosis and Neuroimmunology
Review
Published on 18 Apr 2023
in T Cell Biology
Original Research
Published on 18 Apr 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 18 Apr 2023
in Inflammation
Case Report
Published on 18 Apr 2023
in Primary Immunodeficiencies
Original Research
Published on 18 Apr 2023
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 18 Apr 2023
in Molecular Innate Immunity
Original Research
Published on 18 Apr 2023
in Inflammation
Editorial
Published on 18 Apr 2023
in Molecular Innate Immunity
Review
Published on 18 Apr 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Apr 2023
in Mucosal Immunity
Original Research
Published on 18 Apr 2023
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Published on 18 Apr 2023
in B Cell Biology
Original Research
Published on 18 Apr 2023
in Cancer Immunity and Immunotherapy
Editorial
Published on 18 Apr 2023
in Comparative Immunology
Original Research
Published on 18 Apr 2023
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Case Report
Published on 18 Apr 2023
in Cancer Immunity and Immunotherapy
Original Research
Published on 18 Apr 2023
in Molecular Innate Immunity
Editorial
Published on 18 Apr 2023
in Microbial Immunology